Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

China Medicine Corporation (CHME)

Compare
0.0001
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for CHME
  • Previous Close 0.0000
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0100
  • Volume 2,400
  • Avg. Volume 295
  • Market Cap (intraday) 284,545
  • Beta (5Y Monthly) 182.67
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

www.cmc621.com/cmc/index.php

281

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CHME

View More

Performance Overview: CHME

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CHME
96.67%
S&P 500 (^GSPC)
13.73%

1-Year Return

CHME
0.00%
S&P 500 (^GSPC)
1.42%

3-Year Return

CHME
50.00%
S&P 500 (^GSPC)
10.72%

5-Year Return

CHME
99.50%
S&P 500 (^GSPC)
103.89%

Compare To: CHME

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHME

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.17%

  • Return on Assets (ttm)

    7.82%

  • Return on Equity (ttm)

    6.63%

  • Revenue (ttm)

    65.76M

  • Net Income Avi to Common (ttm)

    -113.32k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.85M

  • Total Debt/Equity (mrq)

    3.22%

  • Levered Free Cash Flow (ttm)

    -44.62M

Research Analysis: CHME

View More

Company Insights: CHME

Research Reports: CHME

View More

People Also Watch